Abstract
The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.
MeSH terms
-
COVID-19 / epidemiology
-
COVID-19 / prevention & control*
-
COVID-19 / virology
-
Delayed Diagnosis / statistics & numerical data
-
Delivery of Health Care / methods
-
Delivery of Health Care / statistics & numerical data
-
Health Personnel / statistics & numerical data
-
Humans
-
Medical Oncology / methods
-
Medical Oncology / statistics & numerical data
-
Medical Oncology / trends
-
Neoplasms / diagnosis*
-
Neoplasms / therapy*
-
Pandemics
-
SARS-CoV-2 / physiology
-
Time-to-Treatment / statistics & numerical data